Federal grants to Simulations Plus Inc
Simulations Plus Inc in Lancaster, North Carolina received $2.9 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was National Center for Advancing Translational Sciences, with $1.7 million. In fiscal 2025 it was awarded $248,087.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$2.9 million
- Awards6
- Awarded in FY 2025$248,087
- Largest award$1.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | -$522,155 |
| FY 2022 | 3 | $1.2 million |
| FY 2023 | 2 | $1.1 million |
| FY 2024 | 4 | $905,749 |
| FY 2025 | 1 | $248,087 |
Programs that fund Simulations Plus Inc
| Program | Awards | Amount |
|---|---|---|
| National Center for Advancing Translational Sciences | 1 | $1.7 million |
| Food and Drug Administration Research | 4 | $865,847 |
| Biomedical Research and Research Training | 1 | $306,872 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $2.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Software for predicting liver injury from biologics drug candidates using data from a human liver microphysiology system - the goal of this project is to develop novel technologies for predicting biologics-induced liver injury caused by anti-inflammatory biologics such as ANTI-IL6 receptor antibody | National Center for Advancing Translational Sciences | February 25, 2022 | $1.7 million |
| Dermal drug product quality and bioequivalence assessment through advanced mam and pbpk simulation - abstract - dermal drug product quality and bioequivalence assessment through advanced mam and pbpk simulation the office of generic drugs (OGD) is tasked with reviewing sponsor applications for derma | Food and Drug Administration Research | September 2, 2021 | $500,000 |
| Development and validation of a workflow to conduct virtual bioequivalence studies using pbbm-pbpk models - development and validation of a workflow to conduct virtual bioequivalence studies using pbbm- pbpk models. – project summary this project aims to define and validate a workflow to demonstrate | Food and Drug Administration Research | September 12, 2023 | $499,032 |
| From bench to bioequivalence: in vitro mechanistic understanding of asd drug products in simulated gastrointestinal conditions - from bench to bioequivalence: in vitro mechanistic understanding of asd drug products in simulated gastrointestinal conditions – project abstract the findings from this pr | Food and Drug Administration Research | September 2, 2024 | $498,970 |
| Development and validation of a pbpk/pd modeling strategy for ophthalmic drug products to support translation from preclinical species to human | Food and Drug Administration Research | August 3, 2021 | $320,000 |
| Improving similarity scoring in drug discovery: solving by solvating - identifying molecules with similar shape and characteristics to known ligands has proven useful in several areas of drug discovery and development, from ligand-based virtual screening (LBVS) to scaffold-hopping. The underlying as | Biomedical Research and Research Training | September 6, 2024 | $306,872 |
Questions people ask
How much federal grant money does Simulations Plus Inc get?
$2.9 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Simulations Plus Inc the most?
The Department of Health and Human Services, with $2.9 million in 6 awards.
What is Simulations Plus Inc's largest federal grant?
$1.7 million under National Center for Advancing Translational Sciences, with its first action in the period on February 25, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Simulations Plus Inc?
Its largest are National Center for Advancing Translational Sciences, Food and Drug Administration Research and Biomedical Research and Research Training.
Largest federal grant recipients in North Carolina · Federal grants in North Carolina